EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver

Bellinda Lantzberg, Yanira Zeyn, Robert Forster, Lin Jian, Dominik Schauenburg, Christoph Hieber, Lutz Nuhn, Tianjiao Zhou, Maria J S A Silva, Kaloian Koynov, Hu-Lin Jiang, Seah Ling Kuan und 3 weitere

Journal of Controlled Release · 2025

DOI: 10.1016/j.jconrel.2025.113705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Bellinda Lantzberg und 14 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany. Hauptthemen laut MEDLINE: Nanoparticle Drug Delivery System, Serum Albumin, Human, Immunologic Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Max-Planck-Gesellschaft, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanocarriers can improve the therapeutic efficiency of small molecule immunomodulators or inhibitors, which is important for immunotherapy of liver diseases or cancer. Macromolecular protein carriers, such as human serum albumin (HSA), could provide better penetration compared to large nanoparticles (>50 nm) but are hampered by systemic biodistribution. To overcome these limitations, inspired by the natural glycogen structure, we have designed the HSA nanocarrier (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nanoparticle Drug Delivery SystemSerum Albumin, HumanImmunologic FactorsToll-Like Receptor 7Toll-Like Receptor 8Liver DiseasesLiver NeoplasmsLiverTissue DistributionImmunotherapyMannoseGlycogenMice, Inbred C57BLFemaleAnimalsMice

Stichwörter der Autor:innen

Albumin-carrierBiomacromolecular therapeuticsImmunotherapyNano-immunotherapyNanomedicineTrimannose targeting

Substanzen

Nanoparticle Drug Delivery SystemSerum Albumin, HumanToll-Like Receptor 7Toll-Like Receptor 8Immunologic FactorsMannoseGlycogen

Autor:innen und Institutionen

  • Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.
  • Department of Dermatology, University Medical Center of Johannes Gutenberg-University Mainz, Obere Zahlbacher Straße 63, 55131 Mainz, Germany.
  • Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany.
  • Faculty for Chemistry and Pharmaceutics, Julius-Maximilians-University Würzburg, Röntgenring 11, 97070 Würzburg, Germany.
  • Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany; State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009, PR China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009, PR China.

Förderung

  • Max-Planck-Gesellschaft
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Lantzberg, B., Zeyn, Y., Forster, R., Jian, L., Schauenburg, D., Hieber, C., Nuhn, L., Zhou, T., Silva, M. J. S. A., Koynov, K., Jiang, H. L., Kuan, S. L., Bros, M., Opatz, T., & Weil, T. (2025). Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.113705

Vancouver

Lantzberg B, Zeyn Y, Forster R, Jian L, Schauenburg D, Hieber C, et al. Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.113705

BibTeX
@article{Lantzberg2025,
  author = {Lantzberg, Bellinda and Zeyn, Yanira and Forster, Robert and Jian, Lin and Schauenburg, Dominik and Hieber, Christoph and Nuhn, Lutz and Zhou, Tianjiao and Silva, Maria J S A and Koynov, Kaloian and Jiang, Hu-Lin and Kuan, Seah Ling and Bros, Matthias and Opatz, Till and Weil, Tanja},
  title = {Glycogen-inspired trimannosylated serum albumin nanocarriers for targeted delivery of toll-like receptor 7/8 agonists to immune cells and liver},
  journal = {Journal of Controlled Release},
  year = {2025},
  doi = {10.1016/j.jconrel.2025.113705}
}
Kostenlos starten →